Nadir prostate-specific antigen as a predictor of progression to androgen-independent prostate cancer

被引：0
|
作者：
Benaim, EA
Page, CM
Lam, PM
Roehrborn, CG
机构：
[1] Univ Texas, SW Med Ctr, Dept Urol, Dallas, TX USA
[2] N Texas Vet Affairs Hlth Care Ctr, Dallas, TX USA
来源：
JOURNAL OF UROLOGY | 2002年 / 168卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：379 / 379
页数：1
相关论文
共 50 条
  • [1] Usefulness of prostate-specific antigen nadir as predictor of androgen-independent progression of metastatic prostate cancer
    Morote, J
    Esquena, S
    Abascal, JM
    Trilla, E
    Cecchini, L
    Raventós, CX
    Orsola, A
    Planas, J
    Catalán, R
    Reventós, J
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2005, 20 (04) : 209 - 216
  • [2] Nadir prostate-specific antigen best predicts the progression to androgen-independent prostate cancer
    Morote, J
    Trilla, E
    Esquena, S
    Abascal, JM
    Reventos, J
    INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (06) : 877 - 881
  • [3] Nadir prostate-specific antigen as a predictor of progression to an drogen-independent prostate cancer
    Benaim, EA
    Pace, CM
    Lam, PM
    Roehrborn, CG
    UROLOGY, 2002, 59 (01) : 73 - 78
  • [4] Clinical predictors of androgen-independent prostate cancer and survival in the prostate-specific antigen era
    Oefelein, MG
    Ricchiuti, VS
    Conrad, PW
    Goldman, H
    Bodner, D
    Resnick, MI
    Seftel, A
    UROLOGY, 2002, 60 (01) : 120 - 124
  • [5] The Progression to Androgen-Independent Prostate Cancer
    Matusik, Robert J.
    JOURNAL OF ANDROLOGY, 2010, : 23 - 23
  • [6] Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific: Antigen gene in the LNCaP prostate tumour model
    Sato, N
    Gleave, ME
    Bruchovsky, N
    Rennie, PS
    Goldenberg, SL
    Lange, PH
    Sullivan, LD
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1996, 58 (02) : 139 - 146
  • [7] NF-κB activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer
    Chen, CD
    Sawyers, CL
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (08) : 2862 - 2870
  • [8] Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy
    Huang, Shu-Pin
    Bao, Bo-Ying
    Wu, Ming-Tsang
    Choueiri, Toni K.
    Goggins, William B.
    Liu, Chia-Chu
    Huang, Chao-Yuan
    Pu, Yeong-Shiau
    Yu, Chia-Cheng
    Wu, Tony T.
    Huang, Chun-Nung
    Huang, Chun-Hsiung
    Wu, Wen-Jeng
    AGING MALE, 2012, 15 (01) : 34 - 41
  • [9] Prostate-Specific Antigen Nadir and Time to Prostate-Specific Antigen Nadir Following Maximal Androgen Blockade Independently Predict Prognosis in Patients with Metastatic Prostate Cancer
    Hong, Seok Young
    Cho, Dae Sung
    Kim, Sun Il
    Ahn, Hyun Soo
    Kim, Se Joong
    KOREAN JOURNAL OF UROLOGY, 2012, 53 (09) : 607 - 613
  • [10] PROSTATE-SPECIFIC ANTIGEN NADIR AND TIME TO PROSTATE-SPECIFIC ANTIGEN NADIR FOLLOWING MAXIMAL ANDROGEN BLOCKADE INDEPENDENTLY PREDICT THE PROGNOSIS IN PATIENTS WITH METASTATIC PROSTATE CANCER
    Sun, I
    Seok, Y.
    Dea, S.
    Hyun, S.
    Young, S.
    Se, J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 362 - 362
12345